{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:02:56Z","timestamp":1791849776775,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ammonia is thought to be central to the pathogenesis of hepatic encephalopathy (HE), but its prognostic role in acute-on-chronic liver failure (ACLF) is still unknown. We aimed to determine the association between serum ammonia level and short-term prognosis in ACLF. Furthermore, we performed an in-depth evaluation of the independent effect of serum ammonia level on the short-term prognosis of hepatitis B virus (HBV) reactivation-induced ACLF patients. We identified 174 patients as part of prospective observational studies in patients with ACLF. Plasma ammonia levels were measured on admission, and several prognostic scores were used to determine the prognostic effect of ammonia. The 28-day patient survival was determined. Receiver operating characteristic analysis was used to identify the cut-off points for ammonia values, and multivariable analysis was performed using the Cox proportional hazard regression model. Plasma ammonia was significantly higher in nonsurvivors (83.53\u2009\u00b1\u200943.78 versus 67.13\u2009\u00b1\u200941.77\u00a0\u00b5mol\/L, P\u2009=\u20090.013), and ACLF patients with hyperammonemia had significantly higher 28-day mortality than those without hyperammonemia. Ammonia was also closely related to ACLF grade (P\u2009&lt;\u20090.001) and organ failure, including liver (P\u2009=\u20090.048), coagulation (P\u2009&lt;\u20090.001) and brain (P\u2009&lt;\u20090.001). HBV reactivation serves as the main precipitating factor in the ACLF population. Subgroup analysis showed that ammonia is also a strong prognostic factor in the HBV reactivation-induced ACLF population. Ammonia level is closely correlated with failure of other organs and is an independent risk factor for mortality in ACLF and the special population defined as HBV reactivation-related ACLF. Based on the results from our study, we measured serum ammonia in the population with ACLF, which strongly indicates their prognosis. It serves as an important biomarker and a therapeutic target.<\/jats:p>","DOI":"10.1038\/s41598-020-73603-1","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T10:02:42Z","timestamp":1602496962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure"],"prefix":"10.1038","volume":"10","author":[{"given":"Chenxia","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"73603_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/hep.510290309","volume":"29","author":"JO Clemmesen","year":"1999","unstructured":"Clemmesen, J. O., Larsen, F. S., Kondrup, J., Hansen, B. A. & Ott, P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology (Baltimore, MD) 29, 648\u2013653. https:\/\/doi.org\/10.1002\/hep.510290309 (1999).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"73603_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/hep.30534","volume":"70","author":"Shalimar","year":"2019","unstructured":"Shalimar, et al. Prognostic role of ammonia in patients with cirrhosis. Hepatology (Baltimore, MD) 70, 982\u2013994. https:\/\/doi.org\/10.1002\/hep.30534 (2019).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"73603_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jhep.2010.07.045","volume":"54","author":"DL Shawcross","year":"2011","unstructured":"Shawcross, D. L. et al. Infection and systemic inflammation, not ammonia, are associated with Grade 3\/4 hepatic encephalopathy, but not mortality in cirrhosis. J. Hepatol. 54, 640\u2013649. https:\/\/doi.org\/10.1016\/j.jhep.2010.07.045 (2011).","journal-title":"J. Hepatol."},{"key":"73603_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.cgh.2015.11.018","volume":"14","author":"JM Vierling","year":"2016","unstructured":"Vierling, J. M. et al. Fasting blood ammonia predicts risk and frequency of hepatic encephalopathy episodes in patients with cirrhosis. Clin. Gastroenterol. Hepatol. 14, 903\u2013906. https:\/\/doi.org\/10.1016\/j.cgh.2015.11.018 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"73603_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/lt.24443","volume":"22","author":"R Sawhney","year":"2016","unstructured":"Sawhney, R. et al. Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients. Liver Transpl. 22, 732\u2013742. https:\/\/doi.org\/10.1002\/lt.24443 (2016).","journal-title":"Liver Transpl."},{"key":"73603_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/mcg.0000000000000443","volume":"50","author":"VR Patwardhan","year":"2016","unstructured":"Patwardhan, V. R. et al. Serum ammonia in associated with transplant-free survival in hospitalized patients with acutely decompensated cirrhosis. J. Clin. Gastroenterol. 50, 345\u2013350. https:\/\/doi.org\/10.1097\/mcg.0000000000000443 (2016).","journal-title":"J. Clin. Gastroenterol."},{"key":"73603_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/17474124.2018.1426459","volume":"12","author":"RH Zhao","year":"2018","unstructured":"Zhao, R. H., Shi, Y., Zhao, H., Wu, W. & Sheng, J. F. Acute-on-chronic liver failure in chronic hepatitis B: An update. Expert Rev. Gastroenterol. Hepatol. 12, 341\u2013350. https:\/\/doi.org\/10.1080\/17474124.2018.1426459 (2018).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"73603_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin, S. K. et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific association for the study of the liver (APASL): An update. Hepatol. Int. 13, 353\u2013390. https:\/\/doi.org\/10.1007\/s12072-019-09946-3 (2019).","journal-title":"Hepatol. Int."},{"key":"73603_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hep.27795","volume":"62","author":"Y Shi","year":"2015","unstructured":"Shi, Y. et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology (Baltimore, MD) 62, 232\u2013242. https:\/\/doi.org\/10.1002\/hep.27795 (2015).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"73603_CR10","doi-asserted-by":"publisher","first-page":"25487","DOI":"10.1038\/srep25487","volume":"6","author":"H Li","year":"2016","unstructured":"Li, H. et al. Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B. Sci. Rep. 6, 25487. https:\/\/doi.org\/10.1038\/srep25487 (2016).","journal-title":"Sci. Rep."},{"key":"73603_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrgastro.2013.216","volume":"11","author":"JP Hwang","year":"2014","unstructured":"Hwang, J. P. & Lok, A. S. Management of patients with hepatitis B who require immunosuppressive therapy. Nat. Rev. Gastroenterol. Hepatol. 11, 209\u2013219. https:\/\/doi.org\/10.1038\/nrgastro.2013.216 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73603_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s10620-006-3175-2","volume":"51","author":"M Kumar","year":"2006","unstructured":"Kumar, M., Jain, S., Sharma, B. C. & Sarin, S. K. Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B. Dig. Dis. Sci. 51, 594\u2013599. https:\/\/doi.org\/10.1007\/s10620-006-3175-2 (2006).","journal-title":"Dig. Dis. Sci."},{"key":"73603_CR13","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau, R. et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144, 1426\u20131437. https:\/\/doi.org\/10.1053\/j.gastro.2013.02.042 (2013).","journal-title":"Gastroenterology"},{"key":"73603_CR14","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","volume":"96","author":"AT Blei","year":"2001","unstructured":"Blei, A. T. & Cordoba, J. Hepatic encephalopathy. Am. J. Gastroenterol. 96, 1968\u20131976. https:\/\/doi.org\/10.1111\/j.1572-0241.2001.03964.x (2001).","journal-title":"Am. J. Gastroenterol."},{"key":"73603_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/gutjnl-2015-310275","volume":"66","author":"P Nahon","year":"2017","unstructured":"Nahon, P. et al. Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort). Gut 66, 330\u2013341. https:\/\/doi.org\/10.1136\/gutjnl-2015-310275 (2017).","journal-title":"Gut"},{"key":"73603_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/s0002-9343(02)01477-8","volume":"114","author":"JP Ong","year":"2003","unstructured":"Ong, J. P. et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am. J. Med. 114, 188\u2013193. https:\/\/doi.org\/10.1016\/s0002-9343(02)01477-8 (2003).","journal-title":"Am. J. Med."},{"key":"73603_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup, H. et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the american association for the study of liver diseases and the European Association for the Study of the liver. Hepatology (Baltimore, MD) 60, 715\u2013735. https:\/\/doi.org\/10.1002\/hep.27210 (2014).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"73603_CR18","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/hep.20703","volume":"41","author":"J Polson","year":"2005","unstructured":"Polson, J. & Lee, W. M. AASLD position paper: The management of acute liver failure. Hepatology (Baltimore, MD) 41, 1179\u20131197. https:\/\/doi.org\/10.1002\/hep.20703 (2005).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"73603_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner, R. et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124, 91\u201396. https:\/\/doi.org\/10.1053\/gast.2003.50016 (2003).","journal-title":"Gastroenterology"},{"key":"73603_CR20","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","volume":"130","author":"SW Biggins","year":"2006","unstructured":"Biggins, S. W. et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 130, 1652\u20131660. https:\/\/doi.org\/10.1053\/j.gastro.2006.02.010 (2006).","journal-title":"Gastroenterology"},{"key":"73603_CR21","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/lt.21197","volume":"13","author":"A Luca","year":"2007","unstructured":"Luca, A. et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl. 13, 1174\u20131180. https:\/\/doi.org\/10.1002\/lt.21197 (2007).","journal-title":"Liver Transpl."},{"key":"73603_CR22","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","volume":"61","author":"R Jalan","year":"2014","unstructured":"Jalan, R. et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J. Hepatol. 61, 1038\u20131047. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.012 (2014).","journal-title":"J. Hepatol."},{"key":"73603_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/s0168-8278(02)00436-1","volume":"38","author":"F Nicolao","year":"2003","unstructured":"Nicolao, F. et al. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J. Hepatol. 38, 441\u2013446. https:\/\/doi.org\/10.1016\/s0168-8278(02)00436-1 (2003).","journal-title":"J. Hepatol."},{"key":"73603_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11011-016-9938-3","volume":"32","author":"S Dasarathy","year":"2017","unstructured":"Dasarathy, S. et al. Ammonia toxicity: From head to toe?. Metab. Brain Dis. 32, 529\u2013538. https:\/\/doi.org\/10.1007\/s11011-016-9938-3 (2017).","journal-title":"Metab. Brain Dis."},{"key":"73603_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jhep.2015.11.019","volume":"64","author":"R Jalan","year":"2016","unstructured":"Jalan, R. et al. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. J. Hepatol. 64, 823\u2013833. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.019 (2016).","journal-title":"J. Hepatol."},{"key":"73603_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00134-017-4845-6","volume":"44","author":"N Weiss","year":"2018","unstructured":"Weiss, N., Jalan, R. & Thabut, D. Understanding hepatic encephalopathy. Intens. Care Med. 44, 231\u2013234. https:\/\/doi.org\/10.1007\/s00134-017-4845-6 (2018).","journal-title":"Intens. Care Med."},{"key":"73603_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/gastro\/gow010","volume":"5","author":"S Ravi","year":"2017","unstructured":"Ravi, S., Bade, K. S., Hasanin, M. & Singal, A. K. Ammonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis. Gastroenterol. Rep. 5, 232\u2013236. https:\/\/doi.org\/10.1093\/gastro\/gow010 (2017).","journal-title":"Gastroenterol. Rep."},{"key":"73603_CR28","doi-asserted-by":"publisher","first-page":"CD012410","DOI":"10.1002\/14651858.CD012410.pub2","volume":"5","author":"ET Goh","year":"2018","unstructured":"Goh, E. T. et al. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst. Rev. 5, CD012410. https:\/\/doi.org\/10.1002\/14651858.CD012410.pub2 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"73603_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","volume":"60","author":"J Cordoba","year":"2014","unstructured":"Cordoba, J. et al. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J. Hepatol. 60, 275\u2013281. https:\/\/doi.org\/10.1016\/j.jhep.2013.10.004 (2014).","journal-title":"J. Hepatol."},{"key":"73603_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","volume":"62","author":"M Romero-Gomez","year":"2015","unstructured":"Romero-Gomez, M., Montagnese, S. & Jalan, R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J. Hepatol. 62, 437\u2013447. https:\/\/doi.org\/10.1016\/j.jhep.2014.09.005 (2015).","journal-title":"J. Hepatol."},{"key":"73603_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3449","volume":"13","author":"A Arzumanyan","year":"2013","unstructured":"Arzumanyan, A., Reis, H. M. & Feitelson, M. A. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat. Rev. Cancer 13, 123\u2013135. https:\/\/doi.org\/10.1038\/nrc3449 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"73603_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5114\/ceh.2019.87631","volume":"5","author":"M Pawlowska","year":"2019","unstructured":"Pawlowska, M. et al. Prophylaxis of hepatitis B virus (HBV) infection reactivation\u2014Recommendations of the Working Group for prevention of HBV reactivation. Clin. Exp. Hepatol. 5, 195\u2013202. https:\/\/doi.org\/10.5114\/ceh.2019.87631 (2019).","journal-title":"Clin. Exp. Hepatol."},{"key":"73603_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30890","author":"F De Chiara","year":"2019","unstructured":"De Chiara, F. et al. Ammonia scavenging prevents progression of fibrosis in experimental nonalcoholic fatty liver disease. Hepatology (Baltimore, MD) https:\/\/doi.org\/10.1002\/hep.30890 (2019).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"73603_CR34","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/hep.24273","volume":"53","author":"CR Bosoi","year":"2011","unstructured":"Bosoi, C. R., Parent-Robitaille, C., Anderson, K., Tremblay, M. & Rose, C. F. AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct-ligated rats. Hepatology (Baltimore, MD) 53, 1995\u20132002. https:\/\/doi.org\/10.1002\/hep.24273 (2011).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"73603_CR35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1478-3231.2011.02698.x","volume":"32","author":"G Wright","year":"2012","unstructured":"Wright, G. et al. Reduction in hyperammonaemia by ornithine phenylacetate prevents lipopolysaccharide-induced brain edema and coma in cirrhotic rats. Liver Int. 32, 410\u2013419. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02698.x (2012).","journal-title":"Liver Int."},{"key":"73603_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/gut.2004.061754","volume":"55","author":"V Bhatia","year":"2006","unstructured":"Bhatia, V., Singh, R. & Acharya, S. K. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55, 98\u2013104. https:\/\/doi.org\/10.1136\/gut.2004.061754 (2006).","journal-title":"Gut"},{"key":"73603_CR37","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/hep.21838","volume":"46","author":"W Bernal","year":"2007","unstructured":"Bernal, W. et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology (Baltimore, MD) 46, 1844\u20131852. https:\/\/doi.org\/10.1002\/hep.21838 (2007).","journal-title":"Hepatology (Baltimore, MD)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73603-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73603-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73603-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:45:22Z","timestamp":1670359522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73603-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73603"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73603-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16970"}}